Coherus Biosciences reported $171.32M in Current Liabilities for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US USD 116.57M 1.11M
Akebia Therapeutics AKBA:US USD 187.96M 45.72M
ALKERMES ALKS:US USD 469.56M 31.04M
Alnylam Pharmaceuticals ALNY:US USD 772.79M 115.11M
Amarin AMRN:US USD 287.36M 74.22M
Amgen AMGN:US USD 15.69B 1.36B
Baxter International BAX:US USD 3.71B 208M
Biogen BIIB:US USD 3.93B 1.09B
Biomarin Pharmaceutical BMRN:US USD 521.02M 56.29M
Bluebird Bio BLUE:US USD 126.73M 22.13M
Bristol Myers Squibb BMY:US USD 18.93B 1.98B
Coherus Biosciences CHRS:US USD 171.32M 30.56M
Eli Lilly And LLY:US USD 15.65B 32.2M
Endo International Ordinary Shares ENDP:US USD 543.05M 638.62M
Fujifilm 4901:JP JPY 991.85B 2.28B
Gilead Sciences GILD:US USD 10.42B 1.2B
Horizon Pharma HZNP:US USD 860.61M 69.55M
Ironwood Pharmaceuticals IRWD:US USD 27.12M 3.82M
JAZZ PHA JAZZ:US USD 812.95M 107.51M
Merk MRK:US USD 23B 170M
Myriad Genetics MYGN:US USD 129.1M 9.4M
Pacira Pharmaceuticals PCRX:US USD 131.53M 1.65M
Perrigo Ordinary Shares PRGO:US USD 1.02B 400K
Ptc Therapeutics PTCT:US USD 420.08M 147.29M
Regeneron Pharmaceuticals REGN:US USD 2.88B 154.7M
Revance Therapeutics RVNC:US USD 74.73M 2.49M
Sarepta Therapeutics SRPT:US USD 602.92M 57.35M
Teva Pharmaceutical TEVA:IT USD 11.53B 538M
Vertex Pharmaceuticals VRTX:US USD 2.61B 53.1M
Xencor XNCR:US USD 90.03M 14.99M
Zoetis ZTS:US USD 2.88B 171M